Astellas Pharma ADR (ALPMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 06-2012 | 03-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||
| Net Income | N/A | 1,550,000 | N/A |
| Depreciation Amortization | N/A | 799,000 | N/A |
| Other Working Capital | N/A | 272,000 | N/A |
| Other Operating Activity | 0 | -515,000 | 0 |
| Operating Cash Flow | $N/A | $2,106,000 | $N/A |
| Cash Flows From Investing Activities | |||
| PPE Investments | N/A | -435,000 | N/A |
| Net Acquisitions | N/A | -46,000 | N/A |
| Other Investing Activity | 0 | 164,000 | 0 |
| Investing Cash Flow | $N/A | $-317,000 | $N/A |
| Cash Flows From Financing Activities | |||
| Dividend Paid | N/A | -704,000 | N/A |
| Other Financing Activity | 0 | -3,000 | 0 |
| Financing Cash Flow | $N/A | $-707,000 | $N/A |
| Exchange Rate Effect | N/A | -144,000 | N/A |
| Beginning Cash Position | N/A | 2,140,000 | N/A |
| End Cash Position | N/A | 3,078,000 | N/A |
| Net Cash Flow | $N/A | $938,000 | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | N/A | 2,106,000 | N/A |
| Free Cash Flow | 0 | 2,106,000 | 0 |